天坛生物(600161.SH)一季度净利润预降17.5%左右

格隆汇4月8日丨天坛生物(600161.SH)公布，经财务部门初步测算，预计2022年一季度实现归属于上市公司股东的净利润与上年同期相比，将减少2654.56万元左右，同比减少17.50%左右。

归属于上市公司股东的扣除非经常性损益的净利润与上年同期相比，将减少3432.4万元左右，同比减少22.83%左右。

本期业绩预减的主要原因是销量减少带来收入以及利润降低。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.